FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the UBS Global Healthcare Conference in New York.
Norbert W. Bischofberger, Gilead’s Executive Vice President, R&D and Chief Scientific Officer, will provide an overview of the company at the conference on Monday, May 23 at 9:30 a.m. Eastern Time.
Norbert W. Bischofberger, Gilead’s Executive Vice President, R&D and Chief Scientific Officer, will provide an overview of the company at the conference on Monday, May 23 at 9:30 a.m. Eastern Time.
